1.How Many High Risk Korean Patients with Osteopenia Could Overlook Treatment Eligibility?.
Dae Hyun YOON ; Dong Hyuk CHOI ; Hyun Gyun JUNG ; Ju Young HEO ; Young Jae JANG ; Yong Soo CHOI
Asian Spine Journal 2014;8(6):729-734
STUDY DESIGN: Retrospective study. PURPOSE: To determine the prevalence of high risk patient with osteopenia requiring pharmacologic treatment and investigate the difference of 10-year fracture probability whether bone mineral density (BMD) include or not in Korean FRAX model. OVERVIEW OF LITERATURE: Many people with the fracture have osteopenia rather than osteoporosis, and BMD alone could be considered as a chance to prevent fracture. METHODS: Three hundred sixty-nine patients who was diagnosed as osteopenia were divided into two groups according to age (group 1, under 65 years; group 2, over 65 years), and 10-year fracture probabilities were calculated by FRAX algorithm with and without femur neck T-score. RESULTS: The high risk patients of the fracture who had above 3% of 10-year hip fracture probability were 15 cases in group 1 and 121 cases in group 2. In 193 patients of group 1, the mean 10-year fracture probability with BMD was significantly higher than the results without BMD (hip fracture: p=0.04, major osteoporotic fracture: p=0.01). Unlike the results of the group 1, the mean 10-year fracture probability without BMD was significantly higher than the results with BMD in 176 patients of group 2 (hip fracture: p=0.01, major osteoporotic fracture: p=0.01). CONCLUSIONS: Total of 136 cases (36.8%) as a high risk of the fracture with osteopenia could be overlooked treatment eligibility in Korean. The Korean FRAX model without BMD could be effective in predicting fracture risk especially in the individuals who were over 65 years.
Bone Density
;
Bone Diseases, Metabolic*
;
Femur Neck
;
Hip
;
Humans
;
Osteoporosis
;
Osteoporotic Fractures
;
Prevalence
;
Retrospective Studies
;
Risk Assessment
2.Treatment of advanced gastric cancer with 5-fluorouracil, etoposide and cisplatin(FEP).
Joung Soon JANG ; Young Hyuk IM ; Sung Soo YOON ; Jae Yong LEE ; Dae Seog HEO ; Yung Jue BANG ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(5):702-707
No abstract available.
Etoposide*
;
Fluorouracil*
;
Stomach Neoplasms*
3.Ischemic Stroke after Overdose of Oral Quetiapine
Tae Hwan YOON ; Gyihyaon YUN ; Jae Young JOO ; Hyun Goo KANG ; Sung Hyuk HEO ; Bum Joon KIM
Journal of the Korean Neurological Association 2019;37(3):301-303
No abstract available.
Quetiapine Fumarate
;
Stroke
4.Clinical Outcomes of Bilateral Stent-in-Stent Placement Using Self-Expandable Metallic Stent for High-Grade Malignant Hilar Biliary Obstruction.
Ja Yoon HEO ; Hee Seung LEE ; Jun Hyuk SON ; Sang Hyub LEE ; Seungmin BANG
Yonsei Medical Journal 2018;59(7):827-833
PURPOSE: Endoscopic bile duct decompression using bilateral self-expandable metallic stents (SEMSs) deployed via a stent-in-stent (SIS) method is considered a preferred procedure for malignant hilar biliary obstruction (MHBO). However, occlusion thereof occurs frequently. Here, we investigated stent patency duration and risk factors related to stent obstruction with bilateral SIS placement for MHBO at two large centers. MATERIALS AND METHODS: The present study reviewed data on patients with MHBO who underwent endoscopic biliary drainage using the SIS method. Clinical outcomes, including stent patency duration and patient overall survival, were analyzed. Factors associated with stent patency were evaluated using Cox proportional hazards models. RESULTS: Seventy patients with MHBO underwent endoscopic biliary drainage using the SIS method. Median age was 68 years old, and median follow-up duration was 140 days (interquartile range, 57–329). The proportion of high-grade MHBOs (Bismuth type IV) was 57.1%. Median stent patency duration with the SIS method was 108 days according to Kaplan-Meier curves. Median patient survival analyzed by the Kaplan-Meier method was 181 days. Multivariate analysis indicated that higher baseline bilirubin (> 6.1 mg/dL) as an independent risk factor related to stent patency (p < 0.05). CONCLUSION: In endoscopic biliary decompression using SEMS placed with the SIS method, obstructive jaundice was a risk factor for stent patency. The SIS method for high-grade MHBO showed short stent patency.
Bile Ducts
;
Bilirubin
;
Decompression
;
Drainage
;
Follow-Up Studies
;
Humans
;
Jaundice, Obstructive
;
Methods
;
Multivariate Analysis
;
Proportional Hazards Models
;
Risk Factors
;
Stents*
6.A prospective randomized study of cisplatin versus PEV(cisplatin, etoposide, vinblastine) chemotherapy in advanced non-small cell lung cancer.
Ki Hyeong LEE ; Won Ki KANG ; Joung Soon JUNG ; Sung Soo YOON ; Young Hyuk IM ; Jae Yong LEE ; Young Suk PARK ; Chang In SUH ; Dae Seog HEO ; Yung Jue BANG ; Young Soo SHIM ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(2):256-267
No abstract available.
Carcinoma, Non-Small-Cell Lung*
;
Cisplatin*
;
Drug Therapy*
;
Etoposide*
;
Prospective Studies*
7.Prosthetic rehabilitation for a patient with CO-MI discrepancy.
Seung Sik CHOO ; Yoon Hyuk HEO ; Lee Ra CHO ; Chan Jin PARK
Journal of Dental Rehabilitation and Applied Science 2015;31(3):273-282
Centric occlusion-maximum intercuspation (CO-MI) discrepancy is one of main causes of evoking premature contact and resultant mandibular shift. These non-physiological conditions can induce temporomandibular disease, periodontitis, and non-carious cervical lesion. Therefore, if CO-MI discrepancy exists in patients who need extensive prosthetic rehabilitation, it must be corrected and then physiological occlusion must be restored. This report describes the treatment procedure of removing CO-MI discrepancy and prosthetic rehabilitation in a patient with 3.5 mm discrepancy, multiple caries and periodontitis. Proper mandibular position and modified opening & closing movement were confirmed by ARCUSdigma II and transcranial radiograph.
Centric Relation
;
Humans
;
Periodontitis
;
Rehabilitation*
8.Extramedullary Solitary Plasmacytoma of the Lymph Nodes.
Min KIM ; Hyuk LEE ; Tae Gil HEO ; Sunhee CHANG ; Hyung Geun YUN ; Seong Min YOON ; Hye Ran LEE
Korean Journal of Medicine 2013;84(5):751-754
Extramedullary plasmacytomas are uncommon malignant neoplasms that can occur in any organ. They arise most frequently from the upper aerodigestive tract. Lymph nodes are exceedingly rare sites of extramedullary plasmacytomas. Most extramedullary plasmacytomas of the lymph node arise in the cervical lymph nodes. Here, we report a case of an extramedullary plasmacytoma of the lymph node arising from a cervical lymph node. A 43-year-old male patient was admitted to our hospital and presented with a non-tender mass on the left side of his neck, which had been growing slowly for 1 month. The mass was excised. The pathology showed diffuse infiltration of immature plasma cells that were encapsulated by a layer of lymphoid cells, indicating an extramedullary plasmacytoma. He was treated with local radiation of the left cervical area. As of March 2009, he is doing well and shows no further evidence of the disease.
Humans
;
Lymph Nodes
;
Lymphocytes
;
Male
;
Neck
;
Plasma Cells
;
Plasmacytoma
9.Prediction of Hemorrhagic Transformation and Functional Outcome Using HAT Score in Acute Ischemic Stroke Patients Treated with Intravenous Alteplase.
Sung Hyuk HEO ; Sang Hun YI ; Dokyung LEE ; Kyoung Jin HWANG ; Yu Jin JUNG ; Key Chung PARK ; Tae Beom AHN ; Sung Sang YOON ; Kyung Cheon CHUNG ; Dae Il CHANG
Journal of the Korean Neurological Association 2012;30(2):110-115
BACKGROUND: Intravenous thrombolysis with alteplase is the most effective therapy for acute ischemic stroke, but hemorrhagic transformation (HT) is a potentially dangerous complication of such thrombolysis. Few studies have investigated the predictors of HT after thrombolysis in Korean stroke patients. METHODS: From 2003 to 2009, acute ischemic stroke patients who received intravenous alteplase were included from the prospective stroke registry of Kyung Hee University Hospital. Patients submitted to CT or MRI scans with gradient echo sequences within 12-36 hours of thrombolysis. The Hemorrhage After Thrombolysis (HAT) score [ranging from 0 (minimum risk) to 5 (maximum risk)] was calculated retrospectively for each patient. The predictive ability of the HAT score for HT and symptomatic intracranial hemorrhage (sICH) was calculated using C statistics. RESULTS: Among 151 consecutive patients, HT was confirmed in 35 on follow-up brain imaging. Atrial fibrillation (OR=2.709, 95%CI=1.118-6.567) and low one-third CT scan (OR=3.419, 95%CI=1.281-9.121) increased the risk of HT after intravenous thrombolysis in multivariate logistic regression analysis. HT, sICH (based on the National Institute of Neurological Disorders and Stroke and the Safe Implementation of Treatment in Stroke-Monitoring Study definitions), unfavorable [modified Rankin Scale (mRS) score of 2-6] and poor (mRS score of 3-6) outcomes at 3 months, and mortality at 3 months were increased with higher HAT scores (C statistic=0.632, 0.637, 0.843, 0.670, 0.689, and 0.659, respectively; p=0.018, 0.036, 0.042, 0.002, 0.015, and <0.001). CONCLUSIONS: The HAT score can be used to predict the risk of sICH following intravenous thrombolysis and the long-term clinical outcome.
Atrial Fibrillation
;
Follow-Up Studies
;
Hemorrhage
;
Humans
;
Intracranial Hemorrhages
;
Logistic Models
;
Magnetic Resonance Imaging
;
National Institute of Neurological Disorders and Stroke
;
Neuroimaging
;
Prospective Studies
;
Retrospective Studies
;
Stroke
;
Thrombolytic Therapy
;
Tissue Plasminogen Activator
10.Sleep Disturbances and Predictive Factors in Caregivers of Patients with Mild Cognitive Impairment and Dementia.
Dongwhane LEE ; Sung Hyuk HEO ; Sung Sang YOON ; Dae Il CHANG ; Sangeui LEE ; Hak Young RHEE ; Bon D KU ; Key Chung PARK
Journal of Clinical Neurology 2014;10(4):304-313
BACKGROUND AND PURPOSE: We examined the characteristics of sleep disturbances and sleep patterns in the caregivers of patients with amnestic mild cognitive impairment (aMCI) and dementia. METHODS: We prospectively studied 132 patients (60 with aMCI and 72 with dementia) and their caregivers, and 52 noncaregiver controls. All caregivers and controls completed several sleep questionnaires, including the Pittsburgh Sleep Quality Index (PSQI). The patients were administered neuropsychological tests and the neuropsychiatric inventory to evaluate their behavioral and neuropsychiatric symptoms of dementia (BPSD). RESULTS: The PSQI global score was 6.25+/-3.88 (mean+/-SD) for the dementia caregivers and 5.47+/-3.53 for the aMCI caregivers. The Insomnia Severity Index (ISI) and short form of the Geriatric Depression Scale (GDS-S) predicted higher PSQI global scores in aMCI caregivers, and higher scores for the ISI, Epworth Sleepiness Scale (ESS), and GDS-S in dementia caregivers. BPSD, including not only agitation, depression, and appetite change in dementia patients, but also depression, apathy, and disinhibition in aMCI patients, was related to impaired sleep quality of caregivers, but nighttime behavior was not. Age and gender were not risk factors for disturbed sleep quality. CONCLUSIONS: Dementia and aMCI caregivers exhibit impaired quality of sleep versus non-caregivers. ISI, GDS-S, and ESS scores are strong indicators of poor sleep in dementia caregivers. In addition, some BPSD and parts of the neuropsychological tests may be predictive factors of sleep disturbance in dementia caregivers.
Alzheimer Disease
;
Apathy
;
Appetite
;
Caregivers*
;
Dementia*
;
Dementia, Vascular
;
Depression
;
Dihydroergotamine
;
Humans
;
Mild Cognitive Impairment*
;
Neuropsychological Tests
;
Prospective Studies
;
Risk Factors
;
Sleep Initiation and Maintenance Disorders
;
Surveys and Questionnaires